- Home
- LENZ vs SABR Comparison
LENZ vs SABR Comparison
Compare LENZ & SABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LENZ | SABR |
|---|---|---|
| Founded | 2019 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 609.5M | 627.9M |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | LENZ | SABR |
|---|---|---|
| Price | $20.40 | $1.34 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $56.25 | $4.15 |
| AVG Volume (30 Days) | 1.1M | ★ 4.8M |
| Earning Date | 03-18-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.41 |
| Revenue | $17,500,000.00 | ★ $3,034,040,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $203.46 | $3.91 |
| P/E Ratio | ★ N/A | $0.94 |
| Revenue Growth | N/A | ★ 8.86 |
| 52 Week Low | $14.43 | $1.20 |
| 52 Week High | $50.40 | $4.63 |
Technical Indicators
Market Signals| Indicator | LENZ | SABR |
|---|---|---|
| Relative Strength Index (RSI) | 54.39 | 44.39 |
| Support Level | $19.02 | $1.20 |
| Resistance Level | $21.80 | $1.38 |
| Average True Range (ATR) | 1.46 | 0.09 |
| MACD | 0.84 | 0.01 |
| Stochastic Oscillator | 76.93 | 42.19 |
Price Performance
Historical ComparisonAbout LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
About SABR Sabre Corporation
Sabre holds the number-two air booking volume share in the global distribution system industry. The travel solutions segment represented 91% of total 2024 revenue, split between distribution (79% of segment sales) and airline IT solutions (21%) revenue. The company sold its growing hotel IT solutions division (9% of revenue) to TPG in 2025 for $960 million in net proceeds. Transaction fees, which are mostly tied to volume and not price, account for the bulk of sales and profits.